Anti-EpCAM monoclonal antibody K931

Drug Profile

Anti-EpCAM monoclonal antibody K931

Alternative Names: Anti-EpCAM monoclonal antibody - Heidelberg Pharma; K 931; WX K931

Latest Information Update: 20 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator VU University Medical Center
  • Developer Wilex
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Epithelial cell adhesion molecule inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 15 May 2003 Anti-EpCAM monoclonal antibody K931 has been exclusively licensed to Wilex for the treatment of advanced solid cancers
  • 15 May 2003 Preclinical development for Solid tumours in Germany (unspecified route)
  • 15 May 2003 Preclinical development for Solid tumours in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top